Zobrazeno 1 - 10
of 47
pro vyhledávání: '"A. R. Antunez"'
Autor:
Sky W. Brubaker, Isabella R. Walters, Emily M. Hite, Lorena R. Antunez, Emma L. Palm, Hans H. Funke, Bryan L. Steadman
Publikováno v:
Vaccines, Vol 12, Iss 7, p 761 (2024)
Many vaccines require multiple doses for full efficacy, posing a barrier for patient adherence and protection. One solution to achieve full vaccination may be attained with single-administration vaccines containing multiple controlled release doses.
Externí odkaz:
https://doaj.org/article/f2e421d3bef147e388480d33a7ca911b
Autor:
Sakshi Bajoria, Lorena R. Antunez, Ozan S. Kumru, Mark Klempner, Yang Wang, Lisa A. Cavacini, Sangeeta B. Joshi, David B. Volkin
Publikováno v:
Journal of Pharmaceutical Sciences.
Autor:
J. R. Antunez, M. J. Valladares Garrido, Christian R. Mejia, C. Pulido Medina, L. R. Barría, J. A. Herrera, R. Aguilar, T. R. Aveiro Róbalo, Danai Valladares Garrido
Publikováno v:
Pakistan Journal of Medical and Health Sciences. 15:1418-1423
Objective: to identify the factors associated with the academic use of smartphones in medical students from 40 faculties in Latin America. Material and Methods: A cross-sectional study was conducted in medical students from 40 faculties in Latin Amer
Autor:
Jian Xiong, Lorena R. Antunez, Mark S. Klempner, Ozan S. Kumru, Sangeeta B. Joshi, Yue Hu, John M. Hickey, Yang Wang, David B. Volkin, Lisa A. Cavacini
Publikováno v:
Journal of Pharmaceutical Sciences
Enterotoxigenic Escherichia coli (ETEC) is a major cause of diarrheal disease among children in developing countries, and there are no licensed vaccines to protect against ETEC. Passive immunization by oral delivery of ETEC-specific secretory IgAs (s
Autor:
Vineet Gupta, Lorena R. Antunez, Soraia Saleh-Birdjandi, Ozan S. Kumru, Richard Pospisil, Anders Lilja, Gerhard Fuhrmann, Lee Smith, David B. Volkin, Sangeeta B. Joshi
Publikováno v:
Journal of Virological Methods. 301:114440
Traditional virus infectivity titration methods for lymphocytic choriomeningitis virus (LCMV) are laborious, time-consuming, and low-throughput (e.g., focus forming unit (FFA) assay). In this report, we developed a high-throughput reverse transcripti
Autor:
Sangeeta B. Joshi, David M. Robinson, Geoffrey S. Diemer, Eddy Sayeed, David B. Volkin, Lorena R. Antunez, Soraia Saleh-Birdjandi, Sjoerd van den Worm, Patrizia Caposio, Klaus Früh, Ozan S. Kumru, Wilma Perez
Publikováno v:
Vaccine
Live attenuated viral vaccine/vector candidates are inherently unstable and infectivity titer losses can readily occur without defining appropriate formulations, storage conditions and clinical handling practices. During initial process development o
Publikováno v:
Journal of pharmaceutical sciences. 108(12)
Combining autoantigens with immune-modulating drugs has emerged as an attractive approach to selectively reinstate tolerance in autoimmune diseases. The disparate properties of autoantigens and small-molecule immunosuppressants commonly used to treat
Publikováno v:
Molecular Pharmaceutics. 13:1731-1737
Most vaccines contain aluminum adjuvants; however, their exact mechanism of action remains unclear. A novel mechanism by Shi and colleagues proposes aluminum adjuvants may enhance immune activation by binding and reorganizing lipids that are key comp
Autor:
Sharadvi Thati, Joshua Sestak, Bradley P. Sullivan, Brittany L. Hartwell, Lorena R. Antunez, Cory Berkland
Publikováno v:
Journal of Pharmaceutical Sciences. 104:346-361
Continued development of multivalent nanomaterials has provided opportunities for the advancement of antigen-specific immunotherapies. New insights emerge when considering the backdrop of vaccine design, which has long employed multivalent presentati
Autor:
Brittany L. Hartwell, Matthew A. Christopher, J. Daniel Griffin, Lorena R. Antunez, Cory Berkland, Laura Northrup, Chad J. Pickens
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 266
Current therapies for autoimmune diseases focus on treating the symptoms rather than the underlying disease cause. A major setback in improving current therapeutics for autoimmunity is the lack of antigen specificity. Successful antigen-specific immu